These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12218637)

  • 1. Telomerase activity, telomere length, and apoptosis: a comparison between acquired cholesteatoma and squamous cell carcinoma.
    Watabe-Rudolph M; Rudolph KL; Averbeck T; Buhr T; Lenarz T; Stöver T
    Otol Neurotol; 2002 Sep; 23(5):793-8. PubMed ID: 12218637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis in meatal skin, cholesteatoma and squamous cell carcinoma of the ear.
    Ergün S; Carlsöö B; Zheng X
    Clin Otolaryngol Allied Sci; 1999 Aug; 24(4):280-5. PubMed ID: 10472461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of telomerase activity in cholesteatoma otitis media.
    Goh EK; Lee BJ; Wang SG; Chon KM; Kim CM
    J Laryngol Otol; 2001 Nov; 115(11):881-4. PubMed ID: 11779302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biological diagnosis of congenital and acquired cholesteatoma on the basis of differences in telomere length.
    Kojima H; Miyazaki H; Shiwa M; Tanaka Y; Moriyama H
    Laryngoscope; 2001 May; 111(5):867-73. PubMed ID: 11359168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
    Kuczkowski J; Pawelczyk T; Bakowska A; Narozny W; Mikaszewski B
    Otol Neurotol; 2007 Feb; 28(2):204-7. PubMed ID: 17255888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity and cell proliferation index in cholesteatoma.
    Lee SH; Jang YH; Tae K; Park YW; Kang MJ; Kim KR; Park CW
    Acta Otolaryngol; 2005 Jul; 125(7):707-12. PubMed ID: 16012031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlations of telomere length and telomerase activity to radiosensitivity of human laryngeal squamous carcinoma cells].
    Xiao CY; Zhou FX; Liu SQ; Xie CH; Dai J; Zhou YF
    Ai Zheng; 2005 Jun; 24(6):653-6. PubMed ID: 15946472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
    Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
    Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage.
    Albanell J; Lonardo F; Rusch V; Engelhardt M; Langenfeld J; Han W; Klimstra D; Venkatraman E; Moore MA; Dmitrovsky E
    J Natl Cancer Inst; 1997 Nov; 89(21):1609-15. PubMed ID: 9362159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant middle ear squamous cell carcinoma mimicking as cholesteatoma.
    Tomazic PV; Ropposch T; Karpf EF; Nemetz U; Braun EM; Lackner A; Walch C
    Otol Neurotol; 2012 Jul; 33(5):e39-40. PubMed ID: 22193618
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of telomerase and its associate genes expression in the maintenance of telomere length in squamous cell carcinoma of the esophagus.
    Hsu CP; Lee LW; Shai SE; Chen CY
    World J Gastroenterol; 2005 Nov; 11(44):6941-7. PubMed ID: 16437597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-3, caspase-8, and nuclear factor-kappaB expression in human cholesteatoma.
    Miyao M; Shinoda H; Takahashi S
    Otol Neurotol; 2006 Jan; 27(1):8-13. PubMed ID: 16371840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible immortalization of Hodgkin and Reed-Sternberg cells: telomerase expression, lengthening of telomere, and inhibition of apoptosis by NF-kappaB expression.
    Ohshima K; Sugihara M; Haraoka S; Suzumiya J; Kanda M; Kawasaki C; Shimazaki K; Kikuchi M
    Leuk Lymphoma; 2001 Apr; 41(3-4):367-76. PubMed ID: 11378550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer.
    Zhang DK; Ngan HY; Cheng RY; Cheung AN; Liu SS; Tsao SW
    Eur J Cancer; 1999 Jan; 35(1):154-60. PubMed ID: 10211104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.
    Asai A; Kiyozuka Y; Yoshida R; Fujii T; Hioki K; Tsubura A
    Anticancer Res; 1998; 18(3A):1465-72. PubMed ID: 9673357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased telomerase activity and elevated hTERT mRNA expression during multistage carcinogenesis of squamous cell carcinoma of the lung.
    Shibuya K; Fujisawa T; Hoshino H; Baba M; Saitoh Y; Iizasa T; Sekine Y; Suzuki M; Hiroshima K; Ohwada H
    Cancer; 2001 Aug; 92(4):849-55. PubMed ID: 11550157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas.
    Leufke C; Leykauf J; Krunic D; Jauch A; Holtgreve-Grez H; Böhm-Steuer B; Bröcker EB; Mauch C; Utikal J; Hartschuh W; Purdie KJ; Boukamp P
    Oncogene; 2014 Jul; 33(27):3506-18. PubMed ID: 23955078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis.
    Begus-Nahrmann Y; Hartmann D; Kraus J; Eshraghi P; Scheffold A; Grieb M; Rasche V; Schirmacher P; Lee HW; Kestler HA; Lechel A; Rudolph KL
    J Clin Invest; 2012 Jun; 122(6):2283-8. PubMed ID: 22622037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of telomerase in non-melanoma skin cancer.
    Boldrini L; Loggini B; Gisfredi S; Zucconi Y; Di Quirico D; Biondi R; Cervadoro G; Barachini P; Basolo F; Pingitore R; Fontanini G
    Int J Mol Med; 2003 May; 11(5):607-11. PubMed ID: 12684697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of telomere dysfunction bestow a selective disadvantage during the progression of human oral squamous cell carcinoma.
    Gordon KE; Ireland H; Roberts M; Steeghs K; McCaul JA; MacDonald DG; Parkinson EK
    Cancer Res; 2003 Jan; 63(2):458-67. PubMed ID: 12543803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.